Holmusk, USA, Inc.

Holmusk, USA, Inc. is a healthcare data analytics and artificial intelligence company specializing in behavioral health and mental health informatics rather than a traditional EMR/EHR vendor. Founded in Singapore in 2015 with U.S. headquarters in New York, Holmusk operates a fundamentally different business model from conventional electronic health record systems.

The company's flagship platform, NeuroBlu, is an AI-powered real-world data and analytics solution purpose-built for behavioral health. Rather than providing clinical documentation tools, Holmusk aggregates, normalizes, and analyzes real-world evidence from mental health and substance use disorder treatment settings. The platform processes structured and unstructured clinical data from existing EMR systems to generate predictive insights, treatment optimization recommendations, and population health analytics.

Holmusk maintains one of the world's largest behavioral health databases, with de-identified patient records spanning depression, anxiety, schizophrenia, bipolar disorder, ADHD, and substance use disorders. The company partners with mental health providers, health systems, pharmaceutical companies, and payers to derive actionable insights from clinical data that already exists in their EMR systems.

Key differentiators include deep domain expertise in psychiatric measurement-based care, proprietary natural language processing for mental health clinical notes, and longitudinal outcome tracking across multiple care settings. Holmusk's AI models are trained specifically on behavioral health data patterns, addressing the unique challenges of mental health documentation including subjective assessments, varied symptom presentations, and treatment response variability.

The platform integrates with existing EMR systems through HL7 FHIR APIs and traditional data extracts, positioning itself as a complementary analytics layer rather than a replacement system. Holmusk serves academic medical centers, community mental health centers, psychiatric hospitals, and integrated delivery networks focused on behavioral health.

Target customers are typically enterprise-scale organizations managing behavioral health populations of 10,000+ patients, pharmaceutical companies conducting real-world evidence studies, and health plans seeking to improve mental health outcomes and reduce costs. The solution requires significant data infrastructure and governance capabilities, making it best suited for organizations with mature data operations.

Holmusk's market position is as a specialized behavioral health data science platform rather than a point-of-care EMR, competing more with analytics vendors and research data aggregators than traditional EMR vendors like Epic or Cerner in the behavioral health space.